Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology.

BMC biotechnology

Volumn 12, Issue 1, 2012, Pages

  Ma, Donghui ^a   Baruch, Dror ^b   Shu, Youmin ^b   Yuan, Kehu ^b   Sun, Zairen ^b   Ma, Kaiyan ^b   Hoang, Toan ^b   Fu, Wei ^b   Min, L ^b   Lan, Zhu Sheng ^b   Wang, Fangxun ^b   Mull, Lori ^b   He, Wei Wu ^b  

^a Origene Technologies Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; DNA BINDING PROTEIN; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; PCYT1A PROTEIN, HUMAN; TUMOR MARKER;

ANTIBODY SPECIFICITY; ARTICLE; CELL STRAIN HEK293; CHEMISTRY; CROSS REACTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; METHODOLOGY; PROTEIN MICROARRAY;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CARCINOMA, NON-SMALL-CELL LUNG; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; CROSS REACTIONS; DNA-BINDING PROTEINS; ENDONUCLEASES; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84869214417     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-12-88     Document Type: Article

References (0)